Keywords:

cerebral small vessel disease, lacunar infarction, white matter hyperintensities, microbleed

References

Sudlow CLM, Warlow CP. comparable studies of the incidence of stroke and its diseased types. Results from an international collaboration. Stroke 1997 ; 28 : 491-99.

Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic plangency imaging : systemic review and meta-analysis. BMJ 2010 ; 341 : 3666.

Gorelick PB, Scuteri A, Black SE, et alabama. vascular contributions to cognitive stultification and dementia : a instruction for healthcare master from the American Heart Association / American Stroke Association. Stroke 2011 ; 42 : 2672-713.

Pantoni L. Cerebral small vessel disease : from pathogenesis and clinical characteristics to remedy challenges. Lancet Neurol 2010 ; 9 : 689-701.

Joanna MW, Colin S, Martin D. Mechanism of sporadic cerebral little vessel disease : insights from neuroimaging. Lancet Neurol 2013 ; 12 : 483-97.

Moody DM, Brown WR, Challar VR, et aluminum. Periventricular venous collagenosis : association with leukoariosis. Radiology 1995 ; 194 : 469-76.

Furuta A, Nobuyoshi N, Nishihara Y, et alabama. medullary arteries in aging and dementia. Stroke1991 ; 22 : 442-46.

Andreas C, David JW. cerebral microbleeds : detection, mechanisms and clinical challenges. future Neurol 2011 ; 6 ( 5 ), 587-611.

Masahito Y. Cerebral amyloid angiopathy : issue concepts. Journal of stroke 2015 ; 17 ( 1 ) : 17-30.

Louis RC. Lacunar infarct and small vessel disease : pathology and Pathophysiology. Journal of stroke 2015 ; 17 ( 1 ) : 2-6.

Donnan GA, Bladin PF, Berkovic SF, et alabama. The stroke syndrome of striatocpsular infarct. Brain 1991 ; 114 : 51-70.

Vincent M, Jong SK. Prevention and management of minor vessel disease. Journal of stroke 2015 ; 17 ( 2 ) : 111-122.

Joanna MW, Eric ES, Geert B, et aluminum. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013 ; 12 : 822-38.

van Dijk EJ, Breteler MM, Schmidt R, et alabama. The association between blood pressure, high blood pressure, and cerebral white topic lesions : cardiovascular determinants of dementia sketch. high blood pressure 2004 : 44 : 625-630.

Bakker SL, de Leeuw FE, de Groot JC, et alabama. Cerebral vasomotor reactivity and cerebral white matter lesions in the aged. neurology 1999 ; 52 : 578-583.

Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, et alabama. Incidence, expression, and predictors of worsening white count on serial cranial magnetic resonance image in aged : The Cardiovascular Health Study. Stroke 2005 ; 36 : 56-61.

Xiong Y, Wong A, Cavalieri M, et aluminum. Prestroke statins, progress of white matter hyperintewnsity, and cognitive decline in stroke patients with confluent white matter hyperintensities. Neurotherapeutics 2014 ; 11 : 606-611.

O ’ Brien JT, Erkinjuntti T, Reisberg B, et alabama. vascular cognitive stultification. Lancet Neurol 2003 ; 2 : 89–98.

Koga H, Takashima Y, Murakawa R, et aluminum. cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling aged individuals. J Stroke Cerebrovasc Dis 2009 ; 18 : 32–37.

Vermeer, SE, Prins MD, Heijer T, et alabama. mum brain infarcts and the gamble of dementia and cognitive descent. N Engl J Med 2003 ; 348 : 1215–22.

Pantoni L. Leukoaraiosis : from an ancient term to an actual marker of poor prognosis. Stroke 2008 ; 39 : 1401–03.

Ferro JM, Madureira S. Age-related whiten matter changes and cognitive deterioration. J Neurol Sci 2002 ; 203–204 : 221–25.

Jokinen H, Kalska H, Ylikoski R, et aluminum, for the LADIS group. Longitudinal cognitive refuse in subcortical ischemic vascular disease — the LADIS analyze. Cerebrovasc Dis 2009 ; 27 : 384–91.

Rosano C, Brach J, Longstreth Jr WT, et aluminum. quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural genius abnormalities in high-functioning elder adults. Neuroepidemiology 2006, 26 ( 1 ) : 52-60.

Sibon I, Fenelon G, Quinn NP, et alabama. vascular paralysis agitans. J Neurol 2004, 251 ( 5 ) : 513-524.

Srikanth V, Beare R, Blizzard L, et alabama. Cerebral white matter lesions, gait, and the hazard of incident falls : a prospective population-based survey. Stroke 2009, 40 ( 1 ) : 175-180.

Ryuji Sakakibara, Jalesh Panicker, Clare J Fowler, et alabama. vascular dissoluteness : incontinence in the aged due to ischemic egg white matter changes. Neurol Int. 2012 Jun 14 ; 4 ( 2 ) : e13.

Rebecca L. Brookes, Vanessa Herbert, Andrew J. Lawrence, et aluminum. Depression in small-vessel disease relates to whiten matter ultrastructural wrong, not disability. Neurology. 2014 Oct 14 ; 83 ( 16 ) : 1417–1423.

Howard J. Aizenstein, Andrius Baskys, Maura Boldrini, et alabama. vascular low consensus report – a critical update. BMC Med. 2016 ; 14 : 161.

Palumbo V, Boulanger JM, Hill MD, et aluminum, for the CASES Investigators. Leukoaraiosis and intracerebral shed blood after thrombolysis in acuate stroke. Neurology 2007 ; 68 : 1020–24.

Dannenberg S, Scheitz JF, Rozanski M, et aluminum. Number of cerebral microbleeds and risk of intracerebral bleeding after intravenous thrombolysis. Stroke 2014 ; 45:2900-2905.

Benavente OR, Hart RG, McClure LA, et alabama. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012 ; 367 : 817-825.

Uchiyama S, Shinohara Y, Katayama Y, et aluminum. benefit of cilostazol in patients with high hazard of bleed : subanalysis of cilostazol stroke prevention study 2. Cerebrovasc Dis 2014 ; 37 : 296-303.

Pergola PE, White CL, Graves JW, et aluminum, for the SPS3 Investigators. Reliability and cogency of blood pressure measurement in the Secondary
Prevention of Small Subcortical Strokes study. Blood Press Monit 2007 ; 12 : 1-8.

Majon M, Sigurdur S, Olafur K, et alabama. joint effect of mid- and late-life lineage coerce on the brain ; The AGES-Reykjavik Study. Neurology 2014 ; 82 :
2187–2195

Amarenco P, Benavente O, Goldstein LB, et aluminum, for the SPARCL Investigators. Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels ( SPARCL ) test by throw subtypes. Stroke 2009 ; 40 : 1405–09.

Mok VC, Lam WW, Fan YH, et alabama. Effects of statins on the progress of cerebral white matter lesion : station hoc analysis of the ROCAS ( Regression of Cerebral Artery Stenosis ) discipline. J Neurol 2009 ; 256 : 750–57